On-demand Scientific Program

Click on the session title that has an icon next to it to view the on-demand recording

Once a video is open, to display full-screen click on the following icon

Tuesday, January 26
Session 1: Opening Plenary Session
Chairs:
Haim Shirin, Shamir Medical Center (Assaf Harofeh)
Oren Shibolet, Tel Aviv Medical Center
Welcome address
Haim Shirin, Shamir Medical Center (Assaf Harofeh)
Hepatitis C: The beginning, the middle and possibly the end
(Supported by Gilead)
Harvey Alter
2020 Nobel Prize laureate
Distinguished NIH Scholar, Bethesda, Maryland, USA
IBD Treatment Paradigm – Future Evolution and Agility
(Supported by Takeda)
Laurent Peyrin-Biroulet
Gastroenterology Department, Nancy University Hospital, France
Session 2: Neurogastroenterology and Motility
Chairs:
Roy Dekel, Tel Aviv Medical Center
Anat Nevo-Shor, Soroka University Medical Center
Session 3: Obesity Treatment – How? Who? When?
Chairs:
Fabiana Benjaminov, Meir Medical Center
Ariel Benson, Hadassah-Hebrew University Medical Center
Brief Introduction
Roy Dekel, Tel Aviv Medical Center
Weight loosing medications: The Israeli status
Liat Barzilay-Yoesph
Meir Medical Center
Take a big breath: New Guidelines for the clinical use of Breath Tests – Lessons from The Israeli Consensus Group
Ram Dickman
Rabin Medical Center and Tel Aviv University
Endoscopic bariatric treatments- Where do we stand?
Reem Sharaiha
Weill Cornell Medicine, Division of Gastroenterology and Hepatological
Department of Medicine, New York, USA
IBS – What are the underlying mechanisms – an update on IBS pathophysiology
Guy Boeckxstaens
Translational Research Center for GI Disorders (TARGID), University
Hospital Leuven, Belgium
Future directions in bariatric endoscopy
Ian Gralnek
Emek Medical Center
IBS – New drugs and future directions What’s in the pipeline: what are
the most promising new drugs in FGID
(Supported by Lapidot)
Jan Tack
Division of Gastroenterology and Hepatology, Leuven University
Hospitals and Translational Research Center for GI Disorders (TARGID),
University Hospital Leuven, Belgium
Panel discussion: Who should treat the obese patient?
Moderator:
Ariel Benson, Hadassah-Hebrew University Medical Center
Panel:
Liat Barzilay-Yoseph, Meir Medical Center
Sigal Fishman, Tel Aviv Sourasky Medical Center
Alon Lang, Sheba Medical Center
Steven Shama, Rabin Medical Center
Reem Sharaiha, Weill Cornell Medicine
The Israeli Neurogastroenterology Group is here for you: A Practical
approach for the treatment IBS – Position paper
Roy Dekel
Tel Aviv Medical Center
ENDOSCOPIC ULTRASOUND (EUS) GUIDED RADIOFREQUENCY ABLATION (RFA) FOR PANCREATIC NEUROENDOCRINE TUMORS (pNET): ARE THE RESULTS STILL GOOD WHEN BASED ON PET-CT ga68 FOLLOW UP?
Joel Schifter; Alain Dancour; Genadi, Sheykman; Menachem Ben Haim; Eran Goldin; Dan M. Livovsky
Shaare Tzedek Medical Center
THE NATURAL HISTORY OF ESOPHAGEAL “ABSENT CONTRACTILITY” AND ITS RELATIONSHIP WITH RHEUMATOLOGIC DISEASES: A CASE-CONTROL STUDY WITH LONG-TERM FOLLOW-UP
Daniel Cohen; Anton Bermont; Vered Richter; Haim Shirin
Shamir Medical Center (Assaf Harofeh)
MOTORISED POWERSPIRAL ENTEROSCOPY (PSE) IS SAFE WITH HIGH CLINICAL IMPACT: PRELIMINARY RESULTS
Dov Wengrower; Mahmoud Mahamid; Eran Goldin
Shaare Zedek Medical Center
POSITIVE FINDINGS ON VIDEO CAPSULE ENDOSCOPY HAS A MINOR
LONG-TERM THERAPEUTIC IMPACT IN PATIENTS WITH IRON
DEFICIENCY ANEMIA

Anton Bermont; Daniel Cohen; Efrat Broide; Vered Rihter; Haim Shirin
Shamir Medical Center (Assaf Harofeh)
Live Q&A
Session 4: Hepatology
Chairs:
Ayelet Partoush Abbou, Bnai Zion Medical Center
Rifaat Safadi, Hadassah-Hebrew University Medical Center
Session 5: IBD
Chairs:
Yehuda Chowers, Rambam Health Care Campus
Vered Richter, Shamir Medical Center (Assaf Harofeh)
How Cholestasis Patients Scratch in 2021?
(Supported by Neopharm)
Rifaat Safadi
Hadassah-Hebrew University Medical Center
Pre-IBD diagnosis: Why should we do it and where are we now?
Johanna Torres
Hospital Beatriz Ângelo, Gastroenterology Division, Universidade de Lisboa, Portugal
Hepatocellular Carcinoma, A Breakthrough After All These Years
(Supported by Roche)
Oren Shibolet
Tel Aviv Medical Center
Current status of combination treatments in IBD
(Supported by Abbvie)
Remo Panaccione
Inflammatory Bowel Disease Clinic, Cumming School of Medicine, University of Calgary, Canada
Immune Mediated DILI of Biologic Therapies & Checkpoints
Assaf Issachar
Rabin Medical Center
Shifting the responsibility switching from IV to SC
(Supported by Perrigo)
Adi Lahat-Zok
Sheba Medical Center
CHRONIC HEPATITIS B INFECTION AND DIABETES MELLITUS: A DOUBLE LIVER TROUBLE?
Fadi Abu Baker; Ilan Green; Gadeer Taha; Yana Davidov; Tawfik Khoury;
Amir Mari; Yael Kopelman; Saif Abu Mouch; Ziv Ben Ari
Hillel Yaffe Medical Center
THE COURSE OF COVID-19 IN IBD PATIENTS TREATED WITH BIOLOGICS
Lev Lichtenstein; Benjamin Koslowsky; Irit Avni-Biron; Baruch Ovadia; Ofer BenBassat; Timna Naftali; Uri Kopylov; Yael Haberman-Ziv; Hagar Banai-Eran; Rami Eliakim; Adi Lahat-Zok; Ayal Hirsch; Eran Zittan; Nitsan Maharshak; Matti Waterman; Eran Israeli; Idan Goren; Jacob E. Ollech; Henit Yanai; Bella Ungar; Benjamin Avidan; Dana Ben Hur; Bernardo Melamud; Ori Segol; Zippora Shalem; Iris Dotan; Selwyn H. Odes; Shomron Ben-Horin; Yf’at Snir; Yael Milgrom; Efrat Broide; Eran Goldin; Shmuel Delgado; Yulia Ron; Nathaniel Aviv Cohen; Eran Maoz; Mia Zborovski; Safwat Odeh; Naim Abu Freha; Eyal Shachar; Yehuda Chowers; Tal Engel; Hila Reiss; Arie Segal; Adar Zinger; Ariella Bar-Gil Shitrit
Ben-Gurion University
HCV Extra Hepatic Manifestations, where are the patients?
(Supported by Abbvie)
Ziv Ben Ari
Sheba Medical Center
Position statement of the Israeli IBD society on treatment strategies 2021
Henit Yanai
Rabin Medical Center
ELEVATED PRE COVID-19 FIB-4 AS A GOOD BIOMARKER OF COVID-19
INFECTION OUTCOME
Yael Milgrom; Asher Shafrir; Eliana Meshrky; David Hakimian;
Mohamad Masarowahr; Rifaat Safadi; Michal Shauly-Aharonov
Hadassah-Hebrew University Medical Center
EFFECTIVNES OF TOFACITINIB IN A REAL-WORLD ISRAELI COHOT OF PATIENTS WITH MODERATE – SEVERE ULCERATIVE COLITIS
Irit Avni-Biron; Ariella Bar-Gil Shitrit; Binyamin Koslowsky; Assaf Levartovsky; Ronny Weisshof; Nathaniel Aviv Cohen; David Hovel; Timna Naftali; Idan Goren; Ifat Snir; Hagar Banai; Jacob Ollech; Yelena Broytman; Iris Dotan; Henit Yanai
Rabin Medical Center
Experts Session: Small molecules for ulcerative colitis – learn from the past anticipate for the future – Small molecules overview and clinical case discussion
(Sponsored by BMS)
Chair: Iris Dotan, Rabin Medical Center
Ariela Bar-Gil Shitrit, Shaare Zedek Medical Center
Adi Lahat-Zok, Sheba Medical Center
Wednesday, January 27
Business meeting of the Israeli Association of Gastroenterology and Liver Diseases
 Session 6: Moderate-severe uncomplicated (also complicated) Crohn’s
disease that you see in your everyday clinic
(Supported by Janssen)
Chairs:
Iris Dotan, Rabin Medical Center
Dan Turner, Shaare Zedek Medical Center
Session 7: Malignancies
Chairs:
Naim Abu-Freha, Soroka Medical Center
Zohar Levi, Rabin Medical Center
Moderate-severe uncomplicated Crohn’s disease – challenges and
therapies
Iris Dotan
Rabin Medical Center
The impact of COVID-19 on screening for CRC in Europe and the US
Nathan Gluck
Tel Aviv Medical Center
The approach to newly diagnosed Crohn’s disease: what every clinician should know in 2021
David Rubin
University of Chicago, Illinois, USA
What every gastroenterologist should know about the new Israeli guidelines concerning Lynch Syndrome
Zohar Levi
Rabin Medical Center
Penetrating disease? The surgeon can wait! Sometimes
Dan Turner
Shaare Zedek Medical Center
New non-invasive methods for early detection of CRC
Elez Vainer
Hadassah-Hebrew University Medical Center
Q&A Panel GENETIC TESTING FOR ASSESSMENT OF LYNCH SYNDROME IN YOUNG PATIENTS WITH POLYPS
Ido Laish; Yael Goldberg; Eitan Friedman; Lior Katz; Zohar Levi; Uri Kopylov; Dan Feldman; Gili Reznick Levi; Elizabeth Half
Sheba Medical Center
IMMUNE FUNCTION IN NEWBORNS OF FEMALES WOITH GESTATIONAL ANTI-TNFα MEDICATION THERAPY FOR INFLAMMATORY BOWEL DISEASES
Batia Weiss; Shomron Ben-Horin; Atar Lev; Efrat Broide; Miri Yavzori;
Adi Lahat; Uri Kopylov; Orit Picard; Rami Eliakim; Yulia Ron; Irit AvniBiron; Anat Yerushalmi-Feler; Amit Assa; Raz Somech; Ariella Bar-Gil
Shitrit Safra Children’s Hospital, Tel Hashomer & Sackler Faculty of Medicine Tel Aviv University
BRCA and CRC
Elizabeth Half
Rambam Health Care Campus
Ido Laish
Sheba Medical Center
INCIDENTALLY DIAGNOSED ASYMPTOMATIC CROHN’S DISEASE: LONGTERM CLINICAL OUTCOMES OF UNTREATED PATIENTS
Ana Grinman; Bella Ungar; Gal Ben Haim; Adi Lahat; Uri Kopylov; Rami
Eliakim; Shomron Ben-Horin
Sheba Medical Center
INCREASED PREVALENCE OF COLORECTAL NEOPLASIA IN PATIENTS WITH IPMN: FACT OR FICTION?
Dana Zelnik Yovel; Lior Bear; Tomer Ziv Baran; Fadi Younis; Erez Scapa; Mati Shnell; Iddo Bar-Yishay; Nir Bar; Erwin Santo; Oren Shibolet; Adam Phillips; Dana Ben-Ami Shor
Shamir Medical Center (Assaf Harofeh)
Live Q&A
Session 8: Microbiome
Chairs:
Lev Lichtenstein, Assuta Ashdod Medical Center
Yehuda Ringel, Meir Medical Center
Session 9: Nutrition
Chairs:
Liat Deutsch, Sourasky Medical Center
Tal Engel, Sheba Medical Center
Identification and Characterization of a Novel Gut Antimicrobial Peptide that Maintains Fungal Commensalism
Eugene Chang
University of Chicago, Illinois, USA
Big data: Why is protein important in the critically ill COVID-19 patient?
(Supported by Neopharm)
Pierre Singer
Rabin Medical Center
Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain
Ehud Rinott
Ben-Gurion University of the Negev
Endomicroscopic detection of atypical food allergy in patients with irritable bowel syndrome – a new diagnostic era?
Ralf Kiesslich
Department of Gastroenterology, Helios HSK Wiesbaden, Germany
Is it time for H. pylori screening for all?
Steven Moss
Brown University, Providence, Rhode Island, USA
CROHN’S DISEASE EXCLUSION DIET INDUCES AND MAINTAINS REMISSION IN ADULTS WITH MILD TO MODERATE CROHN’S DISEASE: A RANDOMIZED CONTROLLED TRIAL (CDED-AD TRIAL)
Henit Yanai; A. Levine; R. Sigall Boneh; A. Hirsch; U. Kopylov; H. Banai Eran; I. Goren; H. Leibovitzh; J. Wardi; L. Abramas; N. Fliss-Isakov; E. Zitan; T. Pfeffer Gik; Iris Dotan; N. Maharshak
Rabin Medical Center
ARTIFICIAL INTELLIGENCE SUCCESSFULLY IDENTIFIES SUBJECTS WHO ARE AT HIGH RISK FOR COLORECTAL CANCER AND WILL NOT SHOW UP FOR COLONOSCOPY WITHIN 6 MONTHS FOLLOWING A POSITIVE FECAL OCCULT BLOOD TEST (FOBT)
Tom Konikoff; Zohar Levy; Iris Dotan; Arnon Cohen; Doron
Caomanesther; Hagit Perry
Rabin Medical Center
Diagnosis of PEI and the role of the PEI-Q
(Supported by Abbott)
J. Enrique Dominguez-Munoz
Department of Gastroenterology, University Hospital of Santiago de
Compostela, Spain
THE INFLAMMATORY BOWEL DISEASE DISK APPLICATION: A PLATFORM TO ASSESS PATIENTS PRIORITIES AND EXPECTATIONS FROM TREATMENT
Vered Richter; Timna Naftali; Amir Mari; Tawfik Khoury; Efrat Broide
Shamir Medical Center (Assaf Harofeh)
CORRELATION BETWEEN TONGUE TOPOGRAPHY AND GASTROINTESTINAL
PATHOLOGY: MACHINE LEARNING, PILOT STUDY
Igor Uchitel; Elad Schiff; Andrawus Beany; Tova Rainis
Technion
Live Q&A
Session 10: Closing Plenary Session
Chairs:
Lior Katz, Hadassah-Hebrew University Medical Center
Michal Openhaim, Clalit Health Services
Human organoid models for GI diseases
Hans Clevers
Hubrect Institute for Developmental Biology and Stem Cell Research (KNAW), The Netherlands
Physical examination panel discussion
Moderator:
Lior Katz, Hadassah-Hebrew University Medical Center
Panel:
Efrat Broide, Shamir Medical Center
Reut Lutsky, Clalit Health Services
Nimrod Kimchi, Bat-Yamon Medical Center
Michal Openhaim, Clalit Health Services
Doron Schwartz, Soroka University Medical Center
A lobby for the public
Linor Deutsch
Co-founder & CEO Lobby99
Outstanding Abstracts and Committee Summary
Naim Abu-Freha, Soroka Medical Center
Lior Katz, Hadassah-Hebrew University Medical Center
Experts Session: Eosinophilic Esophagitis
(Sponsored by Rafa)
Javier Molina-Infanta, Hospital San Pedro de Alcantara, Caceres, Spain
Yehuda Ringel, Meir Medical Center
Noam Zevit, Schneider Children’s Medical Center of Israel